EMEA-001464-PIP01-13 - paediatric investigation plan

amlodipine

Ramipril

Key facts

• Active Substance:
  • amlodipine
  • Ramipril
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/0180/2013
• PIP number:
  EMEA-001464-PIP01-13
• Pharmaceutical form(s):
  Capsule, hard
• Condition(s) / indication(s):
  Treatment of hypertension
• Route(s) of administration:
  Oral use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  30/07/2013

Decision

P/0180/2013: EMA decision of 30 July 2013 on the granting of a product-specific waiver for amlodipine / ramipril (EMEA-001464-PIP01-13)

AdoptedReference Number: EMA/419109/2013